Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
General Internal Medicine
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
When do you consider indefinite anticoagulation in someone with first episode of distal/calf vein DVT?
Does your approach in this population differ compared to proximal DVTs?
Related Questions
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
How would you manage distal DVT in first trimester of pregnancy?
How do you manage a patient with no history of miscarriage but who is unable to conceive, who has a positive lupus anticoagulant without diagnosis of antiphospholipid syndrome?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
What are your top takeaways in Classical Hematology from ASH 2024?
Does PT/PTT elevation due to severe vitamin K deficiency protect against thrombosis?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?